Nucala 100 mg Injection

Nucala 100 mg contains Mepolizumab is a breakthrough treatment for patients whose asthma or inflammatory conditions are not adequately controlled by standard inhalers or steroids. As an IL-5 antagonist, Nucala specifically targets eosinophils—a type of white blood cell that, when elevated, causes significant swelling and inflammation in the lungs and blood vessels.

Key Benefits of Nucala Therapy

• Reduced Asthma Attacks: Clinically proven to lower the rate of severe asthma flare-ups requiring hospitalization.

• Steroid Reduction: Many patients are able to reduce their daily oral corticosteroid dose while on Nucala.

• Better Breathing: Improves overall lung function and reduces daily symptoms like wheezing and shortness of breath.

• Multi-Condition Support: Effective for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and rare conditions like EGPA and HES.

How Nucala 100 mg is Administered

Nucala is intended for long-term maintenance and is given once every 4 weeks.

• Injection Sites: The abdomen, thigh, or upper arm.

• Maintenance Dose: For most adults with asthma, the dose is a single 100 mg injection.

• Note for EGPA/HES: Patients with EGPA or HES typically require a 300 mg dose, administered as three separate 100 mg injections at least 5 cm apart.

Storage and Cold Chain Requirements

As a biologic, Nucala must be handled with care:

• Refrigeration: Store at 2°C to 8°C. Do not freeze.

• Light Protection: Keep in the original carton until the time of use.

• Milan Medicals Guarantee: We utilize specialized cold-chain packaging and temperature-monitored shipping to ensure your Nucala arrives at peak potency.